|
|||||
|
|
Rationale for bipolar androgen therapy (BAT) for metastatic prostate cancer |
|
| Authors: | John T. Isaacs W. Nathaniel Brennen Samuel R. Denmeade |
| Affiliation: | The Prostate Cancer Program, The Department of Oncology at the Sidney Kimmel Comprehensive Cancer Center and Brady Urological Institute, The Department of Urology, The Johns Hopkins School of Medicine, Baltimore, MD, USA |
| Abstract: | |
| Keywords: | |